![Alan Forman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Forman
Directeur/Membre du Conseil chez
JBG SMITH PROPERTIES
Fortune : 83 164 $ au 31/05/2026
Profil
Alan S.
Forman is currently Director at Lirum Therapeutics, Inc. since 2023.
Mr. Forman is a Member of the National Association of Corporate Directors (Virginia).
Mr. Forman is Lead Independent Trustee at JBG SMITH Properties since 2017.
Mr. Forman is Independent Trustee at JBG SMITH Properties LP.
Formerly, Mr. Forman was Director at Yale University Endowment from 1990 to 2022.
Mr. Forman was Director at Kimpton Group Holding LLC.
Mr. Forman was Director at Stemline Therapeutics, Inc. from 2015 to 2020.
Mr. Forman was Investments Director at Yale Investments Office from 1997 to 2022.
Mr. Forman was Trustee at Acadia Realty Trust.
Mr. Forman completed undergraduate studies at Dartmouth College in 1987.
Mr. Forman earned an MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
JBG SMITH PROPERTIES 0,01% | 25/02/2025 | 5 669 ( 0,01% ) | 83 164 $ | 31/05/2026 |
JBG SMITH PROPERTIES -.--% | 30/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Alan Forman
| Sociétés | Poste | Début |
|---|---|---|
| JBG SMITH PROPERTIES | Directeur/Membre du Conseil | 01/01/2017 |
| LIRUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2023 |
National Association of Corporate Directors (Virginia)
 National Association of Corporate Directors (Virginia) Miscellaneous Commercial ServicesCommercial Services Provides online and print information services to directors of public companies | Corporate Officer/Principal | - |
JBG SMITH Properties LP
 JBG SMITH Properties LP Real Estate DevelopmentFinance Part of JBG SMITH Properties, JBG SMITH Properties LP is a real estate investment trust (REIT) specializing in properties within the DC area and Northern Virginia. The company is based in Bethesda, MD. The company focuses on real estate investments and developments in this specific regional market. The company was founded in 1957. The CEO is W. Matthew Kelly. | Directeur/Membre du Conseil | - |
Anciens postes connus de Alan Forman
| Sociétés | Poste | Fin |
|---|---|---|
Yale University Endowment
 Yale University Endowment Investment Trusts/Mutual FundsMiscellaneous The Yale investment committee approves guidelines for investment of the Endowment portfolio, specifying investment objectives, spending policy, and approaches for the investment of each asset category. Although distinct in purpose or restriction, endowment funds are commingled in an investment pool and tracked with unit accounting much like a large mutual fund. Endowment gifts of cash, securities or property are valued and exchanged for units that represent a claim on a portion of the whole investment portfolio. | Directeur en chef des Investissements | - |
Yale Investments Office | Directeur en chef des Investissements | 01/03/2022 |
| STEMLINE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/06/2020 |
Kimpton Group Holding LLC
 Kimpton Group Holding LLC Hotels/Resorts/Cruise linesConsumer Services Operates hotels and restaurants | Directeur/Membre du Conseil | - |
| ACADIA REALTY TRUST | Directeur/Membre du Conseil | - |
Formation de Alan Forman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Yale University Endowment
Yale University Endowment Investment Trusts/Mutual FundsMiscellaneous The Yale investment committee approves guidelines for investment of the Endowment portfolio, specifying investment objectives, spending policy, and approaches for the investment of each asset category. Although distinct in purpose or restriction, endowment funds are commingled in an investment pool and tracked with unit accounting much like a large mutual fund. Endowment gifts of cash, securities or property are valued and exchanged for units that represent a claim on a portion of the whole investment portfolio. | Miscellaneous |
Acadia Realty Trust
 Acadia Realty Trust Real Estate Investment TrustsFinance Operates as a real estate investment trust which owns, acquires, develops and manages retail properties | Finance |
Kimpton Group Holding LLC
Kimpton Group Holding LLC Hotels/Resorts/Cruise linesConsumer Services Operates hotels and restaurants | Consumer Services |
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Association of Corporate Directors (Virginia)
National Association of Corporate Directors (Virginia) Miscellaneous Commercial ServicesCommercial Services Provides online and print information services to directors of public companies | Commercial Services |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JBG SMITH Properties
 JBG SMITH Properties Real Estate Investment TrustsFinance Owns, operates, invests and develops office, multifamily & retail assets | Finance |
JBG SMITH Properties LP
JBG SMITH Properties LP Real Estate DevelopmentFinance Part of JBG SMITH Properties, JBG SMITH Properties LP is a real estate investment trust (REIT) specializing in properties within the DC area and Northern Virginia. The company is based in Bethesda, MD. The company focuses on real estate investments and developments in this specific regional market. The company was founded in 1957. The CEO is W. Matthew Kelly. | Finance |
Yale Investments Office | |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
